Gynecologic Oncology, 0090-8258

Journal

  1. 2020
  2. 2019
  3. AGO-CaRE 1 Investigators, Woelber, L., Eulenburg, C., Kosse, J., Neuser, P., Heiss, C., ... Prieske, K. (2019). Predicting the course of disease in recurrent vulvar cancer - A subset analysis of the AGO-CaRE-1 study. Gynecologic Oncology, 154(3), 571-576. https://doi.org/10.1016/j.ygyno.2019.07.009
  4. Hurley, R. M., Hendrickson, A. E. W., Visscher, D. W., Ansel, P., Harrell, M. I., Wagner, J. M., ... Kaufmann, S. H. (2019). 53BP1 as a potential predictor of response in PARP inhibitor-treated homologous recombination-deficient ovarian cancer. Gynecologic Oncology, 153(1), 127-134. https://doi.org/10.1016/j.ygyno.2019.01.015
  5. 2018
  6. 2017
  7. van de Vrie, R., van Meurs, H. S., Rutten, M. J., Naaktgeboren, C. A., Opmeer, B. C., Gaarenstroom, K. N., ... Buist, M. R. (2017). Cost-effectiveness of laparoscopy as diagnostic tool before primary cytoreductive surgery in ovarian cancer. Gynecologic Oncology, 146(3), 449-456. https://doi.org/10.1016/j.ygyno.2017.06.019
  8. Pouwer, A. W., Hinten, F., van der Velden, J., Smolders, R. G. V., Slangen, B. F. M., Zijlmans, H. J. M. A. A., ... de Hullu, J. A. (2017). Volume-controlled versus short drainage after inguinofemoral lymphadenectomy in vulvar cancer patients: A Dutch nationwide prospective study. Gynecologic Oncology, 146(3), 580-587. https://doi.org/10.1016/j.ygyno.2017.06.031
  9. 2016
  10. Prieske, K., Haeringer, N., Grimm, D., Trillsch, F., Eulenburg, C., Burandt, E., ... Woelber, L. (2016). Patterns of distant metastases in vulvar cancer. Gynecologic Oncology, 142(3). https://doi.org/10.1016/j.ygyno.2016.07.009
  11. Hollestelle, A., van der Baan, F. H., Berchuck, A., Johnatty, S. E., Aben, K. K., Agnarsson, B. A., ... SWE-BRCA (2016). No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer. Gynecologic Oncology, 141(2), 386-401. https://doi.org/10.1016/j.ygyno.2015.04.034
  12. 2015
  13. 2014
  14. 2013
  15. 2012
  16. Evans, J. J., Chitcholtan, K., Dann, J. M., Guilford, P., Harris, G., Lewis, L. K., ... Sykes, P. H. (2012). Adrenomedullin interacts with VEGF in endometrial cancer and has varied modulation in tumours of different grades. Gynecologic Oncology, 125(1), 214-219. https://doi.org/10.1016/j.ygyno.2011.12.429
  17. 2011
  18. Mahner, S., Choschzik, M., Eulenburg, C., Hager, M., Gieseking, F., Schwarz, J., ... Woelber, L. (2011). Number of metastatic lymph nodes and locoregional control in vulvar cancer. Gynecologic Oncology, 121(1), S119-S119. https://doi.org/10.1016/j.ygyno.2010.12.286
  19. 2010
  20. Woelber, L., Mueller, V., Eulenburg, C., Schwarz, J., Carney, W., Jaenicke, F., ... Mahner, S. (2010). Serum carbonic anhydrase IX during first-line therapy of ovarian cancer. Gynecologic Oncology, 117(2), 183-188. https://doi.org/10.1016/j.ygyno.2009.11.029
  21. 2009
  22. 2008
  23. 2007
  24. Zhang, Z., Yu, Y., Xu, F., Berchuck, A., van Haaften-Day, C., Havrilesky, L. J., ... Bast, R. C. (2007). Combining multiple serum tumor markers improves detection of stage I epithelial ovarian cancer. Gynecologic Oncology, 107(3), 526-531. https://doi.org/10.1016/j.ygyno.2007.08.009
Previous 1 2 Next

ID: 1256728